Effects of 4,4'-biphenylene-bis-(2-oxoethylene)-bis-(2,2-diethoxyethyl) dimethylammonium dibromide (DMAE) on catecholamines released by angiotensin.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002395:Catecholamines / Q000494:pharmacology*; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005030:Ethylenes / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology; D012669:Seminal Vesicles / Q000187:drug effects; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects; D014439:Tyramine / Q000494:pharmacology
D001713:Biphenyl Compounds; D002395:Catecholamines; D005030:Ethylenes; D000644:Quaternary Ammonium Compounds; D013566:Sympathomimetics; D000804:Angiotensin II; D012110:Reserpine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D006145:Guanethidine